Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+10.89%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$14.8B
AUM Growth
+$1.41B
Cap. Flow
-$469M
Cap. Flow %
-3.16%
Top 10 Hldgs %
34.28%
Holding
1,313
New
28
Increased
616
Reduced
266
Closed
37

Sector Composition

1 Real Estate 59.2%
2 Technology 7.88%
3 Communication Services 4.42%
4 Consumer Discretionary 3.52%
5 Financials 3.31%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CNST
1101
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$3K ﹤0.01%
89
LMNX
1102
DELISTED
Luminex Corp
LMNX
$3K ﹤0.01%
87
AMPH icon
1103
Amphastar Pharmaceuticals
AMPH
$1.37B
$2K ﹤0.01%
89
ANAB icon
1104
AnaptysBio
ANAB
$613M
$2K ﹤0.01%
60
ANNX icon
1105
Annexon
ANNX
$238M
$2K ﹤0.01%
72
ARCT icon
1106
Arcturus Therapeutics
ARCT
$485M
$2K ﹤0.01%
46
CHRS icon
1107
Coherus Oncology, Inc. Common Stock
CHRS
$150M
$2K ﹤0.01%
135
COLL icon
1108
Collegium Pharmaceutical
COLL
$1.21B
$2K ﹤0.01%
76
DBC icon
1109
Invesco DB Commodity Index Tracking Fund
DBC
$1.26B
$2K ﹤0.01%
100
ENTA icon
1110
Enanta Pharmaceuticals
ENTA
$189M
$2K ﹤0.01%
38
IMVT icon
1111
Immunovant
IMVT
$2.99B
$2K ﹤0.01%
184
ITOS
1112
DELISTED
iTeos Therapeutics
ITOS
$2K ﹤0.01%
66
KROS icon
1113
Keros Therapeutics
KROS
$633M
$2K ﹤0.01%
44
LEGN icon
1114
Legend Biotech
LEGN
$6.66B
$2K ﹤0.01%
40
MRSN icon
1115
Mersana Therapeutics
MRSN
$34M
$2K ﹤0.01%
5
NKTX icon
1116
Nkarta
NKTX
$161M
$2K ﹤0.01%
61
NRIX icon
1117
Nurix Therapeutics
NRIX
$758M
$2K ﹤0.01%
73
TBPH icon
1118
Theravance Biopharma
TBPH
$703M
$2K ﹤0.01%
120
TVTX icon
1119
Travere Therapeutics
TVTX
$1.93B
$2K ﹤0.01%
114
KLRS
1120
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.4M
$2K ﹤0.01%
5
PETQ
1121
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
55
GTHX
1122
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2K ﹤0.01%
72
OCUL icon
1123
Ocular Therapeutix
OCUL
$2.37B
$2K ﹤0.01%
134
OMER icon
1124
Omeros
OMER
$284M
$2K ﹤0.01%
116
PCVX icon
1125
Vaxcyte
PCVX
$4.29B
$2K ﹤0.01%
96